Janus Kinase 1 inhibitors (Nissan Chemical Industries/Keio University School of Medicine)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameJanus Kinase 1 inhibitors (Nissan Chemical Industries/Keio University School of Medicine)
Drug Alias NameJAK1 inhibitors (Nissan Chemical Industries/Keio University School of Medicine)NIP-585
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNissan Chemical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeio UniversityNissan Chemical Corp
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A